IGF1 and IGF2 comprise of the IGF family, contributing largely to the activation of the PI3K/Akt signaling pathway, which was also found dysregulated by the KEGG analysis, thus enhancing the cancerogenesis of HCC (Kasprzak et al., 2017). The gene discussed is IGF2; the disease is hepatocellular carcinoma.